Guest Contributor


People:
Dr Arnold Naimark, Dr Janusz Kozinski, Frank Holler, and Nicholas Ignatieff

Frank Holler

Guest Contributor
June 20, 2005

Frank Holler has joined the board of directors for Genome British Columbia. Holler is currently CEO and fund manager for BC Advantage Funds and has been a prominent executive for several biotechnology firms and has extensive experience in the banking industry. He was president and CEO of both ID Biomedical Corp and Zenon Genetics Inc (now Xenon Pharmaceuticals Inc) and a founding director of Angiotech Pharmaceuticals. He holds an MBA and BA in economics from the Univ of British Columbia….


Other News

Peter Brenders

Dr Chummer Farina

Dan Sinai

Dr Marc Renaud






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.